Psilocybin in the Treatment of Cocaine Use Disorder
- ID
4d76058a5eaf4438- Source org
- PubMed Central
- Author
- Peter S. Hendricks et al.
- Published
- 2026-05-07
- OA status
- gold
- DOI
- 10.1001/jamanetworkopen.2026.11029
- PMID
- —
- PMCID
- PMC13159770
- Citations
- 4
Tags
- cbt
Verification
- identity: ok via crossref · score 1 · checked_at unknown
- legitimacy: keep via unknown · score 0.95 · checked_at unknown
- link: ok via http-check · 2026-07-21T15:52:31.592259+00:00
Cite this entry
BibTeX
@article{allodium:4d76058a5eaf4438,
title = {Psilocybin in the Treatment of Cocaine Use Disorder},
author = {Peter S. Hendricks and Sara Lappan and Richard C. Shelton and Adrienne C. Lahti and Karen L. Cropsey and Matthew W. Johnson and Melissa Bradley and Otto Simonsson and Lori L. Davis and Daniel H. Grossman and Cynthia E. Ortiz},
year = {2026},
journal = {PubMed Central},
doi = {10.1001/jamanetworkopen.2026.11029},
url = {https://doi.org/10.1001/jamanetworkopen.2026.11029}
}RIS
TY - JOUR TI - Psilocybin in the Treatment of Cocaine Use Disorder AU - Hendricks, Peter S. AU - Lappan, Sara AU - Shelton, Richard C. AU - Lahti, Adrienne C. AU - Cropsey, Karen L. AU - Johnson, Matthew W. AU - Bradley, Melissa AU - Simonsson, Otto AU - Davis, Lori L. AU - Grossman, Daniel H. AU - Ortiz, Cynthia E. PY - 2026 PB - PubMed Central DO - 10.1001/jamanetworkopen.2026.11029 UR - https://doi.org/10.1001/jamanetworkopen.2026.11029 ER -
APA
Hendricks, P. S., Lappan, S., Shelton, R. C., Lahti, A. C., Cropsey, K. L., Johnson, M. W., Bradley, M., Simonsson, O., Davis, L. L., Grossman, D. H., & Ortiz, C. E. (2026). Psilocybin in the Treatment of Cocaine Use Disorder. PubMed Central. https://doi.org/10.1001/jamanetworkopen.2026.11029
Related entries
- Efficacy of Disulfiram and Cognitive Behavior Therapy in Cocaine-DependentOutpatients cbtlink inconclusive
- Cognitive-behavioral therapy plus contingency management for cocaine use: Findings during treatment and across 12-month follow-up. cbtlink ok
- Cocaine-negative urine drug screens for persons with cocaine addiction; ACT + contingency management vs. drug counselling plus contingency management; non responders reallocated to modafinil vs. placebo. N=118. Schmitz, J. M., Stotts, A. L., Vujanovic, A. A., Yoon, J. H., Webber, H. E., Lane, S. D., actlink ok
- Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders cbtlink inconclusive
- Effects of mindfulness yoga intervention on physical function, anxiety, inflammatory response, and relapse intention in methamphetamine addicts: a 24-week randomized controlled trial cbtlink ok
- Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression mbctlink inconclusive
- Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development cbtlink ok
- Digitally Delivered Cognitive Behavioral Interventions for Alcohol and Other Drug Use: Meta-Analysis Across Consumption and Psychosocial Outcomes cbtlink ok
- Quality versus quantity: acquisition of coping skills following computerized cognitive–behavioral therapy for substance use disorders cbtlink ok
- Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial mctlink ok